Valuation: SMS Pharmaceuticals Limited

Market Cap 35.11B 369M 319M 298M 273M 514M 522M 3.5B 1.37B 17.6B 1.39B 1.35B 58.17B P/E 2024
30.3x
P/E 2025 27.3x
Enterprise Value 37.8B 397M 344M 321M 294M 554M 562M 3.76B 1.48B 18.95B 1.49B 1.46B 62.63B EV / Sales 2024
2.47x
EV / Sales 2025 2.75x
Free-Float
23.47%
Yield 2024
0.22%
Yield 2025 0.19%
1 day+5.85%
1 week+1.12%
Current month+1.12%
1 month-10.72%
3 months-10.30%
6 months+18.90%
Current year+21.81%
1 week 355.5
Extreme 355.5
380
1 month 355.5
Extreme 355.5
411.3
Current year 293.15
Extreme 293.15
447.8
1 year 218.61
Extreme 218.61
447.8
3 years 111.85
Extreme 111.85
447.8
5 years 54.55
Extreme 54.55
447.8
10 years 24
Extreme 24
447.8
Manager TitleAgeSince
Chief Executive Officer 66 29/08/1990
Director of Finance/CFO - 12/09/2017
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 66 29/08/1990
Director/Board Member 38 04/06/2020
Director/Board Member 48 28/05/2018
Change 5-day change 1-year change 3-year change Capi.($)
+5.85%+1.12%+75.89%+209.41% 372M
-0.31%-2.29%+21.68%+67.56% 49.03B
+4.40%+14.46%+66.32%+142.60% 42.33B
-0.89%-0.64%-1.82%+19.63% 12.43B
+0.56%-1.12%+17.97%+70.05% 11.68B
+0.19%+0.77%+31.08%+139.91% 9.12B
+1.99%+4.41%+20.08%+36.28% 7.15B
+1.82%-0.15%+39.86%-12.61% 7.09B
+0.40%+2.02%+10.49%+179.30% 6.76B
+6.44%+8.26%-24.87%+30.54% 5.95B
Average +2.05%+2.58%+25.67%+88.27% 15.19B
Weighted average by Cap. +1.57%+3.74%+31.06%+87.73%

Financials

2024 2025
Net sales 7.09B 74.52M 64.46M 60.2M 55.22M 104M 106M 706M 277M 3.56B 280M 274M 11.75B 7.83B 82.25M 71.14M 66.44M 60.95M 115M 116M 779M 306M 3.92B 309M 302M 12.97B
Net income 498M 5.24M 4.53M 4.23M 3.88M 7.3M 7.41M 49.62M 19.47M 250M 19.66M 19.23M 826M 691M 7.26M 6.28M 5.87M 5.38M 10.12M 10.29M 68.85M 27.02M 347M 27.28M 26.68M 1.15B
Net Debt 2.45B 25.71M 22.24M 20.77M 19.05M 35.83M 36.4M 244M 95.62M 1.23B 96.53M 94.42M 4.05B 2.69B 28.29M 24.47M 22.85M 20.97M 39.43M 40.06M 268M 105M 1.35B 106M 104M 4.46B
Logo SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
Employees
1,470
Date Price Change Volume
07/08/26 ₹378.10 +5.85% 553,999
06/08/26 ₹357.20 -2.02% 179,849
05/08/26 ₹364.55 +0.29% 141,953
04/08/26 ₹363.50 -0.01% 236,700
03/08/26 ₹363.55 -2.77% 299,209

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SMSPHARMA Stock